J&J Seeks Dismissal Of ERISA Fiduciary Breach Suit Over Drug Benefits

(April 23, 2024, 2:51 PM EDT) -- CAMDEN, N.J. — Arguing in part that the sponsor of the self-funded health plans at issue “has every incentive to negotiate the best overall deal,” Johnson and Johnson (J&J) and related defendants asked a New Jersey federal court to dismiss the complaint and strike the jury demand in a putative class case asserting Employee Retirement Income Security Act claims over alleged “mismanagement of prescription-drug benefits.”...